These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4036270)

  • 1. A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection.
    Kark JD; Aynor Y; Peters CJ
    Vaccine; 1985 Jun; 3(2):117-22. PubMed ID: 4036270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P
    Vaccine; 2011 Apr; 29(17):3222-9. PubMed ID: 21354483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up.
    Kark JD; Aynor Y; Peters CJ
    Am J Epidemiol; 1982 Nov; 116(5):808-20. PubMed ID: 6890766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans.
    Niklasson B; Peters CJ; Bengtsson E; Norrby E
    Vaccine; 1985 Jun; 3(2):123-7. PubMed ID: 4036271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
    Barnard BJ
    J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.
    Pittman PR; Liu CT; Cannon TL; Makuch RS; Mangiafico JA; Gibbs PH; Peters CJ
    Vaccine; 1999 Aug; 18(1-2):181-9. PubMed ID: 10501248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of steers, goats and sheep to inactivated Rift Valley Fever vaccine.
    Yedloutschnig RJ; Dardiri AH; Walker JS; Peters CJ; Eddy GA
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):253-60. PubMed ID: 298921
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials.
    Meadors GF; Gibbs PH; Peters CJ
    Vaccine; 1986 Sep; 4(3):179-84. PubMed ID: 3532605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200.
    Frank-Peterside N
    Afr J Med Med Sci; 2000 Jun; 29(2):89-92. PubMed ID: 11379456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rift Valley fever virus vaccine trial: study of side-effects in humans.
    Niklasson B
    Scand J Infect Dis; 1982; 14(2):105-9. PubMed ID: 7201671
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.
    Swanepoel R; Struthers JK; Erasmus MJ; Shepherd SP; McGillivray GM; Erasmus BJ; Barnard BJ
    J Hyg (Lond); 1986 Oct; 97(2):317-29. PubMed ID: 3537118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rift Valley fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius).
    Davies FG; Koros J; Mbugua H
    J Hyg (Lond); 1985 Apr; 94(2):241-4. PubMed ID: 3989285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
    Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
    Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal immunization with rabies vaccine. Inactivated Wistar strain cultivated in human diploid cells.
    Ajjan N; Soulebot JP; Triau R; Biron G
    JAMA; 1980 Dec; 244(22):2528-31. PubMed ID: 7431588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
    Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
    Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.
    Pittman PR; McClain D; Quinn X; Coonan KM; Mangiafico J; Makuch RS; Morrill J; Peters CJ
    Vaccine; 2016 Jan; 34(4):424-429. PubMed ID: 26718688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Rissmann M; Ulrich R; Schröder C; Hammerschmidt B; Hanke D; Mroz C; Groschup MH; Eiden M
    Vaccine; 2017 Jan; 35(4):655-662. PubMed ID: 28012779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.